Dr. Jinsy Andrews, MD

Dr. Andrews practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Andrews' NPI, 1710917232, was assigned on July 3, 2006. Dr. Andrews graduated from Albany Medical College in 2001. Dr. Andrews holds New York license 235741.

Dr. Andrews' primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Andrews' primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Andrews is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Andrews to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Andrews practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Andrews' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Andrews is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Andrews' licenses on file in 4 states: New York, California, New Jersey and Connecticut.

Dmand AI lists alzheimer's disease, lower back pain, muscle disease, muscle weakness and thoracic spine disorders among the conditions Dr. Andrews treats.

CMS data shows 269 Medicare services from Dr. Andrews across 9 procedure codes in 2024, for 72 Medicare patients. Medicare paid $22,698 for them. Every service was in an office.

CMS counts 72 Medicare patients who saw Dr. Andrews in 2024. The largest group is 65 to 74, with 33 patients. 69% of them have high cholesterol, and 67% have high blood pressure. 26% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Andrews' median patient age at 64, with 45% women.

In 2024, Dr. Andrews wrote 644 Medicare Part D claims for 73 patients. 68% of them were for generic drugs. CMS names the drug for 476 of them, across 16 drugs with 11 or more claims each, at $2,755,178 in total drug cost. In 2023, CMS named 350 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Andrews for performance year 2024, reported through an alternative payment model (APM). Dr. Andrews accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Andrews as offering telehealth.

Dmand AI links 61 papers to Dr. Andrews, published from 2013 to 2025. 2025 was the busiest year, with 6. The most frequent topics are Amyotrophic Lateral Sclerosis, Double-Blind Method and Disease Progression. Dr. Andrews has published most often in Amyotroph Lateral Scler Frontotemporal Degener. Dr. Andrews' most frequent co-authors are Jeremy M. Shefner, MD, Merit Ester Cudkowicz, MD and Terry D. Heiman-Patterson, MD.

Dmand AI links Dr. Andrews to 2 clinical trials. Conditions studied include Amyotrophic Lateral Sclerosis, Nerve Degeneration and TDP-43 Proteinopathies.

CMS Open Payments shows 52 general payments to Dr. Andrews from 18 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 73% of the total. Biogen, Inc. paid the most, $19,278. It also lists 14 research payments totaling $5,981 from 2018 to 2025.

Dmand AI lists 2 awards for Dr. Andrews, most recently Fellow of the American Academy of Neurology in 2018.

Dr. Andrews graduated from Albany Medical College in 2001. Dr. Andrews is a member of AAN, AANEM and ANA.

Dr. Andrews is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.